Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov-Dec;136(6):579-585.
doi: 10.1590/1516-3180.2018.0380311018.

What do Cochrane systematic reviews say about interventions for insomnia?

Affiliations

What do Cochrane systematic reviews say about interventions for insomnia?

Florence de Lucca Melo et al. Sao Paulo Med J. 2018 Nov-Dec.

Abstract

Context and objective: Insomnia is a frequent complaint that generates more than five million visits to doctors per year in the United States. This study summarizes all Cochrane systematic reviews (SRs) that evaluated interventions to treat insomnia.

Design and setting: Review of SRs, conducted in the Discipline of Evidence-Based Medicine, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP).

Methods: A sensitive search was carried out in the Cochrane Database of Systematic Reviews to identify Cochrane SRs that assessed the effects of any type of intervention for people with insomnia. The results, main characteristics of the SRs and the certainty of the evidence obtained from them were synthesized and discussed.

Results: Seven SRs were included. They addressed the benefits and harm of acupuncture (n = 1), behavioral interventions (n = 1), music (n = 1), pharmacotherapy (n = 2), phototherapy (n = 1) and physical exercise (n = 1). The certainty of the evidence ranged from moderate to very low.

Conclusion: Acupuncture, music, physical exercise, paroxetine, doxepin, trimipramine and trazodone seem to present some benefit for patients with insomnia. However, the uncertainty around these results means that no robust and definitive recommendations for clinical practice can be made until the benefits and harms from each intervention for patients with insomnia have been confirmed through further studies.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None

Similar articles

Cited by

  • Antidepressants in inflammatory bowel disease.
    Mikocka-Walus A, Ford AC, Drossman DA. Mikocka-Walus A, et al. Nat Rev Gastroenterol Hepatol. 2020 Mar;17(3):184-192. doi: 10.1038/s41575-019-0259-y. Epub 2020 Feb 18. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32071420 Review.

References

    1. Ford ES, Wheaton AG, Cunningham TJ. Trends in outpatients visits for insomnia, sleep apnea, and prescriptions for sleep medications among US adults: findings from the National Ambulatory Medical Care survey 1999-2000. Sleep. 2014;37(8):1283–1293. doi: 10.5665/sleep.3914. - DOI - PMC - PubMed
    1. Wilson SJ, Nutt DJ, Alford C. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol. 2010;24(11):1577–1601. doi: 10.1177/0269881110379307. - DOI - PubMed
    1. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97–111. doi: 10.1053/smrv.2002.0186. - DOI - PubMed
    1. American Academy of Sleep Medicine . International Classification of Sleep Disorders. 3. Darien, IL: American Academy of Sleep Medicine; 2014.
    1. American Psychiatric Association, DSM-5 Task Force . Diagnostic and statistical manual of mental disorders: DSM-5(tm) 5. Arlington, VA, US: American Psychiatric Publishing, Inc.; 2013. - DOI

MeSH terms

Substances